RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | +3.3% | 26,693 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | -62.5% | 26,693 | 0.0% | 0.00% | – |
| Q1 2022 | $80,000 | -29.2% | 26,693 | -37.1% | 0.00% | -100.0% |
| Q4 2021 | $113,000 | -29.4% | 42,462 | -3.6% | 0.00% | 0.0% |
| Q3 2021 | $160,000 | -15.3% | 44,051 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $189,000 | +56.2% | 43,540 | +23.4% | 0.00% | 0.0% |
| Q1 2021 | $121,000 | -32.8% | 35,279 | -31.6% | 0.00% | 0.0% |
| Q4 2020 | $180,000 | +682.6% | 51,548 | +427.2% | 0.00% | – |
| Q3 2020 | $23,000 | +27.8% | 9,778 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +20.0% | 9,778 | 0.0% | 0.00% | – |
| Q1 2020 | $15,000 | -28.6% | 9,778 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | +16.7% | 9,778 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -30.8% | 9,778 | 0.0% | 0.00% | – |
| Q2 2019 | $26,000 | +4.0% | 9,778 | 0.0% | 0.00% | – |
| Q1 2019 | $25,000 | -41.9% | 9,778 | -47.7% | 0.00% | – |
| Q4 2018 | $43,000 | -28.3% | 18,695 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $60,000 | +66.7% | 18,695 | +47.8% | 0.00% | – |
| Q2 2018 | $36,000 | – | 12,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |